Bruce A. Leicher

2017 - Momenta Pharmaceuticals

In 2017, Bruce A. Leicher earned a total compensation of $1.5M as Senior Vice President, General Counsel and Secretary at Momenta Pharmaceuticals, a 5% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$144,200
Option Awards$498,762
Salary$450,626
Stock Awards$405,746
Other$13,331
Total$1,512,665

Leicher received $498.8K in option awards, accounting for 33% of the total pay in 2017.

Leicher also received $144.2K in non-equity incentive plan, $450.6K in salary, $405.7K in stock awards and $13.3K in other compensation.

Rankings

In 2017, Bruce A. Leicher's compensation ranked 6,947th out of 14,666 executives tracked by ExecPay. In other words, Leicher earned more than 52.6% of executives.

ClassificationRankingPercentile
All
6,947
out of 14,666
53rd
Division
Manufacturing
2,573
out of 5,768
55th
Major group
Chemicals And Allied Products
832
out of 2,074
60th
Industry group
Drugs
646
out of 1,730
63rd
Industry
Biological Products, Except Diagnostic Substances
119
out of 316
62nd
Source: SEC filing on April 27, 2018.

Leicher's colleagues

We found five more compensation records of executives who worked with Bruce A. Leicher at Momenta Pharmaceuticals in 2017.

2017

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2017

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2017

Matthew Ottmer

Momenta Pharmaceuticals

Chief Operating Officer

2017

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Operating Officer

2017

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

You may also like